Repatha

2 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Recent coverage examines a real-world study showing Amgen's Repatha lowers heart attack risk by 20% compared to ezetimibe.

5 sources 6 articles v 3 45m ago

◼ Archived Business 🔮 holds ✗

10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

10 sources 10 articles v 8 93d ago